Review Use of luteinising hormone-releasing agonists adjuvant treatment early breast cancer

A systematic review to summarise current evidence about the role of LHRH agonists in the adjuvant treatment of ER+ early breast cancer in pre-menopausal women, with a view to providing evidence to support the information needs of women with breast cancer, clinicians, media and policy makers.

This resource has been superseded in-full or in-part by Review Use of taxanes for neo and adjuvant treatment early and locally advanced breast cancer.

File name: lha-1-use-of-luteinising-ho...juvant-treatment-of-ebc.pdf
File size: 399.83 KB
Cancer Type: Breast cancer
Publication Audience: Resources for health professionals
Year: 2003
Document Status: Rescinded

This resource is 10 years or older and has been rescinded by Cancer Australia. It is available to the public for research and reference purposes only. Cancer Australia assumes no legal liability or responsibility for errors or omissions contained within.

Download PDF

Return to search results